Schedule 13G ownership disclosure
Collegium Pharmaceutical Inc
Common Stock · CUSIP: 19459J104
Event date: 2025-06-30
- Filing-level shares
- 1,584,871.00
- Percent of class
- 4.9%
- Invesco Ltd.
Shares: 1,584,871.00 · Class: 4.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-25-000303
- Form type
- SCHEDULE 13G/A
- Filer
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK 1267565
- Filed
- Aug 07, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership